You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
The need for a consensus on the definition of remission of autoimmune pancreatitis after steroid treatment
  1. Myung-Hwan Kim,
  2. Sung-Hoon Moon
  1. Department of Internal Medicine, University of Ulsan College of Medicine Asan Medical Center, Seoul, South Korea
  1. Correspondence to Dr Myung-Hwan Kim, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Pungnap-2dong, Songpa-gu, Seoul, 138-736, South Korea; mhkim{at}amc.seoul.kr

http://dx.doi.org/10.1136/gut.2009.199513

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We congratulate Kamisawa et al on their recent study1 in which they report the rate of remission and relapse after steroid treatment in autoimmune pancreatitis (AIP). However, we are uncertain that the definition of remission is clear in their study. The authors defined remission as the ‘disappearance of clinical symptoms and resolution of the pancreatic and/or extrapancreatic manifestations on imaging studies’ in their ‘Methods’ section. However, they contradictorily stated that irregularity of the pancreatic ducts and/or bile duct stenosis remained in some patients at remission in their ‘Results’ section.

    The treatment …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.